PMV Pharmaceuticals, Inc.
PMVP
$1.38
$0.042.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.99% | -28.70% | -32.42% | -60.70% | -65.45% |
| Total Depreciation and Amortization | -74.53% | -84.13% | -88.37% | -90.51% | -66.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.08% | -55.11% | -60.41% | 78.21% | 59.85% |
| Change in Net Operating Assets | -94.01% | 78.17% | 157.41% | 421.81% | 212.37% |
| Cash from Operations | -1.71% | -40.53% | -43.48% | -56.40% | -53.91% |
| Capital Expenditure | 80.56% | 61.54% | 95.57% | 91.21% | 91.42% |
| Sale of Property, Plant, and Equipment | -99.64% | -87.65% | -87.65% | 772.41% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -39.27% | 11.78% | 30.53% | 35.40% | 1,032.80% |
| Cash from Investing | -39.49% | 11.42% | 31.53% | 38.24% | 934.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 87.72% | 53.25% | 61.34% | -33.57% | -99.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 87.72% | 53.25% | 61.34% | -33.57% | -99.15% |
| Foreign Exchange rate Adjustments | 400.00% | -66.67% | 120.00% | -130.00% | -116.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -506.36% | -526.21% | -223.21% | -309.45% | 73.47% |